GLP-1 Loading During Elective Percutaneous Coronary Intervention

Last updated: June 5, 2018
Sponsor: Papworth Hospital NHS Foundation Trust
Overall Status: Active - Not Recruiting

Phase

2

Condition

Congestive Heart Failure

Heart Attack (Myocardial Infarction)

Blood Clots

Treatment

N/A

Clinical Study ID

NCT02127996
P01799
  • Ages > 18
  • All Genders

Study Summary

Angina is caused by narrowings or blockages within coronary arteries. Coronary angioplasty and stenting is performed for people with angina to improve the blood supply to the heart by placing metal tubes within the artery using balloon inflation. The procedure risks small but significant damage to the heart muscle downstream of the balloon.

Glucagon like peptide 1 (GLP 1) is a naturally occurring hormone secreted by cells in the gut in response to food. It acts by stimulating the release of insulin. In the heart it acts to increase glucose uptake into cardiac muscle. GLP−1 can protect the heart and improve heart muscle performance in people with coronary artery disease in physiological studies. This study which assesses whether GLP−1 protects the heart during coronary angioplasty and stenting.

The hypothesis is that GLP-1 given during elective coronary angioplasty and stenting will reduce cardiac troponin rise (a measure of heart muscle damage) compared to placebo.

Eligibility Criteria

Inclusion

Inclusion criteria:

  • Undergoing elective PCI

  • Age over 18

  • Able to give informed consent

Exclusion

Exclusion criteria:

  • Severe co-morbidity (expected life expectancy < 6 months)

  • Nicorandil, glibenclamide, sitagliptin, vildagliptin, saxagliptin, linagliptin,liraglutide, exenatide and insulin use

  • Women of child bearing age

  • Breast-feeding women

  • Myocardial infarction within the previous 3 months

  • Baseline elevation of Troponin I before PCI

  • Chronic Renal Impairment (serum creatinine > 160 μmol/l)

Study Design

Total Participants: 193
Study Start date:
March 01, 2015
Estimated Completion Date:
July 31, 2021

Connect with a study center

  • Papworth Hospital

    Cambridge, Cambridgeshire CB23 3RE
    United Kingdom

    Site Not Available

Map preview placeholder

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.